WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis
Chronic Diseases and Translational Medicine · 2018
DOI: 10.1016/j.cdtm.2018.02.004 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Chronic Diseases and Translational Medicine, 2018. Verfasst von Cai-Xia Liang und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Beijing Municipal Science and Technology Commission Major Project
- National Natural Science Foundation of China
Zitieren
APA
Liang, C., Shi, Y., & Han, X. (2018). WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis. Chronic Diseases and Translational Medicine. https://doi.org/10.1016/j.cdtm.2018.02.004
Vancouver
Liang C, Shi Y, Han X. WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis. Chronic Diseases and Translational Medicine. 2018. doi:10.1016/j.cdtm.2018.02.004
BibTeX
@article{Liang2018,
author = {Liang, Cai-Xia and Shi, Yuan-Kai and Han, Xiao-Hong},
title = {WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis},
journal = {Chronic Diseases and Translational Medicine},
year = {2018},
doi = {10.1016/j.cdtm.2018.02.004}
}
EUVIMED